Monomers capable of dimerizing in an aqueous solution, and methods of using same

US11970448B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11970448-B2
Application numberUS-202016929528-A
CountryUS
Kind codeB2
Filing dateJul 15, 2020
Priority dateApr 7, 2011
Publication dateApr 30, 2024
Grant dateApr 30, 2024

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Described herein are monomers capable of forming a biologically useful multimer when in contact with one, two, three or more other monomers in an aqueous media. In one aspect, such monomers may be capable of binding to another monomer in an aqueous media (e.g. in vivo) to form a multimer, (e.g. a dimer). Contemplated monomers may include a ligand moiety, a linker element, and a connector element that joins the ligand moiety and the linker element. In an aqueous media, such contemplated monomers may join together via each linker element and may thus be capable of modulating one or more biomolecules substantially simultaneously, e.g., modulate two or more binding domains on a protein or on different proteins.

First claim

Opening claim text (preview).

What is claimed is: 1. A therapeutic composition comprising a first monomer selected from the group consisting of: and a second monomer selected from the group consisting of: and pharmaceutically acceptable salts, stereoisomers, or hydrates thereof. 2. The therapeutic composition of claim 1 , wherein the first monomer is and the second monomer is 3. A therapeutic composition comprising a first monomer selected from the group consisting of: and a second monomer selected from the group consisting of: and pharmaceutically acceptable salts, stereoisomers, or hydrates thereof.

Assignees

Inventors

Classifications

  • C07D211/26Primary

    with hydrocarbon radicals, substituted by nitrogen atoms · CPC title

  • linked by a carbon chain containing only aliphatic carbon atoms · CPC title

  • linked by a carbon chain containing only aliphatic carbon atoms · CPC title

  • with only one oxygen atom as ring hetero atom in the oxygen-containing ring · CPC title

  • Boronic and borinic acid compounds · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11970448B2 cover?
Described herein are monomers capable of forming a biologically useful multimer when in contact with one, two, three or more other monomers in an aqueous media. In one aspect, such monomers may be capable of binding to another monomer in an aqueous media (e.g. in vivo) to form a multimer, (e.g. a dimer). Contemplated monomers may include a ligand moiety, a linker element, and a connector elemen…
Who is the assignee on this patent?
Univ Cornell, Purdue Research Foundation
What technology area does this patent fall under?
Primary CPC classification C07D211/26. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Apr 30 2024 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).